Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor

Korte SM, Straub RH. Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms. Rheumatology (Oxford). 2019;58(Suppl 5):v35–50.

Article  CAS  PubMed  Google Scholar 

Chavarría C, Casanova MJ, Chaparro M, et al. Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: a multicentre study. J Crohns Colitis. 2019;13(8):996–1002.

Article  PubMed  Google Scholar 

Graff LA, Walker JR, Russell AS, et al. Fatigue and quality of sleep in patients with immune-mediated inflammatory disease. J Rheumatol Suppl. 2011;88:36–42.

Article  PubMed  Google Scholar 

Druce KL, Basu N. Predictors of fatigue in rheumatoid arthritis. Rheumatology (Oxford). 2019;58(Suppl 5):v29–34.

Article  PubMed  Google Scholar 

Katz P. Causes and consequences of fatigue in rheumatoid arthritis. Curr Opin Rheumatol. 2017;29(3):269–76.

Article  PubMed  Google Scholar 

Grimstad T, Norheim KB. Fatigue in inflammatory bowel disease. Tidsskr Nor Laegeforen. 2016;136(20):1721–4.

Article  PubMed  Google Scholar 

Swain MG. Fatigue in chronic disease. Clin Sci (Lond). 2000;99(1):1–8.

Article  CAS  PubMed  Google Scholar 

Davis JM 3rd, Myasoedova E, Gunderson TM, et al. Multimorbidity and fatigue in rheumatoid arthritis: a cross-sectional study of a population-based cohort. Rheumatol Ther. 2020;7(4):979–91.

Article  PubMed  PubMed Central  Google Scholar 

Minnock P, Veale DJ, Bresnihan B, et al. Factors that influence fatigue status in patients with severe rheumatoid arthritis (RA) and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysis. Clin Rheumatol. 2015;34(11):1857–65.

Article  PubMed  PubMed Central  Google Scholar 

Haugeberg G, Hoff M, Kavanaugh A, et al. Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates. Arthritis Res Ther. 2020;22(1):198.

Article  PubMed  PubMed Central  Google Scholar 

Almeida C, Choy EH, Hewlett S, et al. Biologic interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev. 2016;2016(6): CD008334.

PubMed  PubMed Central  Google Scholar 

Yip RML, Yim CW. Role of interleukin 6 inhibitors in the management of rheumatoid arthritis. J Clin Rheumatol. 2021;27(8):e516–24.

Article  PubMed  Google Scholar 

Skoie IM, Dalen I, Omdal R. Effect of biological treatment on fatigue in psoriasis: a systematic review and meta-analysis. Am J Clin Dermatol. 2019;20(4):493–502.

Article  PubMed  Google Scholar 

Shim J, Dean LE, Karabayas M, et al. Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue: results from the BSRBR-AS registry and meta-analysis. Rheumatology (Oxford). 2020;59(11):3408–14.

Article  CAS  PubMed  Google Scholar 

Kvien TK, Conaghan PG, Gossec L, et al. secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis: long-term results of two phase III randomized controlled trials. Arthritis Care Res (Hoboken). 2022;74(5):759–67.

Article  PubMed  Google Scholar 

Reilly E, McGrogan A, Sengupta R. Evaluating patient-reported fatigue and serum biomarkers in axial spondyloarthritis. Rheumatology (Oxford). 2020;59(10):3111–3.

Article  PubMed  Google Scholar 

Laganà B, Vinciguerra M, D’Amelio R. Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatacept. Clin Drug Investig. 2009;29(3):185–202.

Article  PubMed  Google Scholar 

Druce KL, Bhattacharya Y, Jones GT, et al. Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (Oxford). 2016;55(10):1786–90.

Article  CAS  PubMed  Google Scholar 

Wang F, Lin X, Zhao Q, et al. Adverse symptoms with anti-TNF-alpha therapy in inflammatory bowel disease: systematic review and duration-response meta-analysis. Eur J Clin Pharmacol. 2015;71(8):911–9.

Article  CAS  PubMed  Google Scholar 

Vogelaar L, van’t Spijker A, van Tilburg AJ, et al. Determinants of fatigue in Crohn’s disease patients. Eur J Gastroenterol Hepatol. 2013;25(2):246–51.

Article  PubMed  Google Scholar 

van Lint JA, Jessurun NT, Hebing RCF, et al. Patient-reported burden of adverse drug reactions attributed to biologics used for immune-mediated inflammatory diseases. Drug Saf. 2020;43(9):917–25.

Article  PubMed  Google Scholar 

Kosse LJ, Jessurun N, Hebing RCF, et al. Patients with inflammatory rheumatic diseases: quality of self-reported medical information in a prospective cohort event monitoring system. Rheumatology (Oxford). 2020;59(6):1253–61.

Article  PubMed  Google Scholar 

Van Lint J, Bakker T, Ubbink J, et al. OP0208: patients report fatigue as an adverse drug reaction of biologics. Ann Rheum Dis. 2020;79(Suppl 1):129–30.

Article  Google Scholar 

Remicade® Product Information: European Medicines Agency [updated 12 Nov 2021; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/remicade-epar-product-information_en.pdf.

Enbrel® Product Information: European Medicines Agency [updated 25 Mar 2021; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/enbrel-epar-product-information_en.pdf.

Humira® Product Information: European Medicines Agency [updated 29 Jan 2021; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/humira-epar-product-information_en.pdf.

Cimzia® Product Information: European Medicines Agency [updated 7 Apr 2021; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/cimzia-epar-product-information_en.pdf.

Simponi® Product Information: European Medicines Agency [updated 11 Nov 2020; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/simponi-epar-product-information_en.pdf.

Orencia® Product Information: European Medicines Agency [updated 6 Oct 2020; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/orencia-epar-product-information_en.pdf.

Kyntheum® Product Information: European Medicines Agency [updated 27 Jul 2020; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/kyntheum-epar-product-information_en.pdf.

Ilaris® Product Information: European Medicines Agency [updated 25 Feb 2020; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/ilaris-epar-product-information_en.pdf.

Mabthera® Product Information: European Medicines Agency [updated 25 Mar 2021; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/mabthera-epar-product-information_en.pdf.

Cosentyx® Product Information: European Medicines Agency [updated 25 Mar 2021; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/cosentyx-epar-product-information_en.pdf.

Stelara® Product Information: European Medicines Agency [updated 12 Mar 2021; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/stelara-epar-product-information_en.pdf.

Entyvio® Product Information: European Medicines Agency [updated 30 Nov 2020; cited 21 Apr 2021]. https://www.ema.europa.eu/en/documents/product-information/entyvio-epar-product-information_en.pdf.

Remicade® Product Label: US FDA [updated 10 May 2021; cited 2023]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103772s5401lbl.pdf.

Cimzia® Product Label: US FDA [updated 22 Dec 2022; cited 2023]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125160s305lbl.pdf.

Siliq® Product Label: US FDA [updated 15 Feb 2017; cited 2023]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761032lbl.pdf.

Stelara® Product Label: US FDA [updated 29 Jul 2022; cited 2023]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761044s010lbl.pdf.

Truxima® Product Label: US FDA [updated 04 Feb 2022; cited 2023]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761088s018lbl.pdf.

Entyvio® Product Label: US FDA [updated 17 Jun 2022; cited 2023]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125476Orig1s046lbl.pdf.

MedDRA Maintenance and Support Services Organization. Medical Dictionary for Regulatory Activities: Northrop Grumman Corporation. http://www.meddra.org/.

Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.

Article  CAS  PubMed  Google Scholar 

RoActemra® Product Information: European Medicines Agency [updated 14 Sep 2020; cited 11 May 2021]. https://www.ema.europa.eu/en/documents/product-information/roactemra-epar-product-information_en.pdf.

Ćalasan MB, van den Bosch OF, Creemers MC, et al. Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis. Arthritis Res Ther. 2013;15(6):R217.

Article  PubMed  Google Scholar 

Paul F, Cartron G. Infusion-related reactions to rituximab: frequency, mechanisms and predictors. Expert Rev Clin Immunol. 2019;15(4):383–9.

Article  CAS  PubMed  Google Scholar 

Lichtenstein L, Ron Y, Kivity S, et al. Infliximab-related infusion reactions: systematic review. J Crohns Colitis. 2015;9(9):806–15.

Article  PubMed  PubMed Central  Google Scholar 

Katz U, Achiron A, Sherer Y, et al. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev. 2007;6(4):257–9.

Article  CAS  PubMed  Google Scholar 

Church MK, Church DS. Pharmacology of antihistamines. Indian J Dermatol. 2013;58(3):219–24.

Article  PubMed  PubMed Central  Google Scholar 

Bots SJ, Parker CE, Brandse JF, et al. Anti-drug antibody formation against biologic agents in inflammatory bowel disease: a systematic review and meta-analysis. BioDrugs. 2021;35(6):715–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strand V, Balsa A, Al-Saleh J, et al. Immunogenicity of biologics in chronic inflammatory diseases: a systematic review. BioDrugs. 2017;31(4):299–316.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skoie IM, Dalen I, Ternowitz T, et al. Fatigue in psoriasis: a controlled study. Br J Dermatol. 2017;177(2):505–12.

Article  CAS  PubMed  Google Scholar 

Ibn Yacoub Y, Amine B, Laatiris A, et al. Fatigue and severity of rheumatoid arthritis in Moroccan patients. Rheumatol Int. 2012;32(7):1901–7.

Article  PubMed  Google Scholar 

Conley S, Proctor DD, Jeon S, et al. Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health. 2017;40(5):424–34.

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif